AVO Stock Looks Expensive: Buy Now or Wait for Better Entry Point?

Mission Produce (AVO) rallied 13.9% over the past three months, supported by the completed Calavo acquisition, improving volumes (+15% YoY in 2Q FY2026), and an expected $25M in annualized cost synergies within 18 months. However, near-term fundamentals remain pressured: 2Q FY2026 revenues fell 24% YoY to $290.9M as per-unit prices dropped 36%, and adjusted EBITDA declined to $7.1M from $19.1M. Valuation is also a headwind, with a forward 12-month P/E of 17.89X versus a 14.51X industry average, suggesting limited room for execution missteps despite bullish technical momentum.

Analysis

AVO is being priced as a higher-quality compounder, but the business still screens as a cyclical commodity processor with integration optionality layered on top. That combination is dangerous when the earnings denominator is still moving lower: if avocado pricing does not normalize quickly, the premium multiple will likely compress before synergy dollars become visible. In that setup, the cleaner relative winners are diversified peers like DOLE and ADM, which can absorb produce-cycle volatility without needing a successful merger integration to defend valuation.

The key catalyst path is the next 1-2 earnings cycles, not the next 1-2 trading sessions. If oversupply persists, FY26 EPS revisions are likely to drift down again, and the stock’s current re-rating becomes harder to justify. If pricing improves before the Calavo integration is fully digested, AVO can rally sharply, but that is also the main falsifier for a bearish stance. The structural 6-18 month case depends on whether the combined platform actually converts scale into margin expansion rather than just higher revenue base.

The market may be missing that recent strength can reflect scarcity of better ag names rather than a clean fundamental break. That makes the move more fragile than the chart suggests: momentum can persist while estimates stabilize, but once revisions resume lower, the multiple usually follows. I would avoid fighting the trend outright, but I would also resist paying up for a still-cyclical earnings stream with execution risk still early in the integration phase.

Key Decisions for Investors

• Pair trade: short AVO / long DOLE for 1-3 months. Thesis is valuation compression at AVO versus cheaper, more diversified produce exposure at DOLE. Target 10-15% relative downside if FY26 EPS revisions keep slipping; cover if AVO posts two consecutive quarters of stable or rising gross margin.
• If a direct short is preferred, buy AVO 3-6 month put spreads on strength or into the next earnings print. Use a capped-risk structure because upside squeezes are possible if avocado pricing normalizes faster than expected. Risk/reward is attractive only if shares remain near premium valuation levels.
• Overweight ADM versus AVO in an ag-staples basket for 6-12 months. ADM carries less single-category pricing risk and does not require merger integration to unlock value; this is a lower-beta way to express caution on AVO's premium multiple.
• Set a hard alert on AVO consensus FY26 EPS and gross margin: if estimates stop falling and margin inflects for two quarters, the bearish relative-value thesis is broken. If not, expect multiple compression first and operational improvement later.